METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): DIAGNOSTIC CRITERIA AND EMERGING PHARMACOTHERAPY . ITFTTDM 2026, 4 (9), 129-31.